Director at AllianceBernstein (NYSE: AB) receives 4,397 restricted units grant

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Stonehill Charles G.T. reported acquisition or exercise transactions in this Form 4 filing.

AllianceBernstein Holding L.P. director Charles G.T. Stonehill received a grant of 4,397 restricted AB Holding Units on May 20, 2026, valued at $38.67 per unit. His direct holdings increased to 29,573 AB Holding Units. The grant vests in three equal 33.33% installments on May 1 of 2027, 2028 and 2029.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Stonehill Charles G.T.

Role null

Type	Security	Shares	Price	Value
Grant/Award	AB Holding Units	4,397	$38.67	$170K

Holdings After Transaction: AB Holding Units — 29,573 shares (Direct, null)

Footnotes (1)

Units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units"). The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 4,397 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 20, 2026; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal 33.33% increments on each of May 1, 2027, 2028 and 2029. Closing price of an AB Holding Unit (NYSE: AB) on the grant date (May 20, 2026).

Key Figures

Restricted units granted: 4,397 units Grant-date price: $38.67 per unit Holdings after grant: 29,573 units +3 more

6 metrics

Restricted units granted 4,397 units AB Holding Units grant on May 20, 2026

Grant-date price $38.67 per unit Closing price on May 20, 2026

Holdings after grant 29,573 units Total AB Holding Units directly held post-transaction

First vesting date 33.33% on May 1, 2027 Initial installment of restricted unit vesting

Second vesting date 33.33% on May 1, 2028 Second installment of restricted unit vesting

Final vesting date 33.33% on May 1, 2029 Final installment of restricted unit vesting

Key Terms

restricted AB Holding Units, Independent Director, vesting, closing price

4 terms

restricted AB Holding Units financial

"granted 4,397 restricted AB Holding Units to the Reporting Person"

Independent Director financial

"each Independent Director recused himself or herself from approving this grant"

An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.

vesting financial

"The AB Holding Units will vest and be delivered in equal 33.33% increments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

closing price financial

"Closing price of an AB Holding Unit (NYSE: AB) on the grant date"

Form 4 Insider Transactions: What Each Field Means →

05/22/2026 - 04:48 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stonehill Charles G.T.

(Last)

(First)

(Middle)

C/O ALLIANCEBERNSTEIN

501 COMMERCE STREET

(Street)

NASHVILLE

TENNESSEE

37203

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALLIANCEBERNSTEIN HOLDING L.P. [ AB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
AB Holding Units⁽¹⁾	05/20/2026		A		4,397⁽²⁾	A	$38.67⁽³⁾	29,573	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units").

2. The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 4,397 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 20, 2026; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal 33.33% increments on each of May 1, 2027, 2028 and 2029.

3. Closing price of an AB Holding Unit (NYSE: AB) on the grant date (May 20, 2026).

Remarks:

	/s/ Charles G. T. Stonehill	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did AllianceBernstein (AB) director Charles G.T. Stonehill report?

Charles G.T. Stonehill reported receiving a grant of 4,397 restricted AB Holding Units. The award was approved by the Board of Directors and represents stock-based compensation rather than an open-market purchase or sale, increasing his direct ownership position in AB Holding Units.

What was the grant-date value of the AB Holding Units awarded to the AllianceBernstein director?

The 4,397 AB Holding Units were valued at $38.67 per unit on the May 20, 2026 grant date. This price reflects the NYSE closing price for an AB Holding Unit that day, as disclosed in the Form 4 footnotes for the reported transaction.

How does the new grant affect Charles Stonehill’s total AB Holding Units?

Following the grant, Charles G.T. Stonehill directly holds 29,573 AB Holding Units. The transaction increased his stake through restricted units awarded as director compensation, as opposed to buying units on the market or disposing of existing holdings reported in this Form 4 filing.

What is the vesting schedule for the restricted AB Holding Units granted to the AllianceBernstein director?

The 4,397 restricted AB Holding Units vest in three equal 33.33% installments on May 1, 2027, May 1, 2028 and May 1, 2029. Units are delivered upon vesting, tying the director’s compensation to AllianceBernstein’s long-term performance and continued board service.

Who approved the restricted AB Holding Units grant to the AllianceBernstein director?

The Board of Directors of AllianceBernstein Corporation, the general partner of AllianceBernstein Holding L.P., approved the grant. Each Independent Director recused himself or herself from approving this specific grant, as disclosed in the Form 4 footnotes describing the award’s approval process.